Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Intralesional Cidofovir application in recurrent laryngeal papillomatosis.

Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Abstract Text:

    annett pudszuhnAnnett Pudszuhn,cornelia welzelCornelia Welzel,marc blochingMarc Bloching,kerstin neumannKerstin Neumann,annett pudszuhnAnnett Pudszuhn,cornelia welzelCornelia Welzel,marc blochingMarc Bloching,kerstin neumannKerstin Neumann,

    Recurrent laryngeal papillomatosis is a benign disease of the larynx often leading to organic and functional restrictions. The therapeutic treatment of choice in larynx-obstructing papillomatosis is at present surgical laser ablation. The effectiveness of adjuvant intralesional injection of the virustaticum Cidofovir has been investigated recently in a variety of therapeutic models. The present case study deals with the treatment of recurrent laryngeal papillomatosis by means of surgical laser ablation of the laryngeal papillomas with adjuvant local injection of the virustaticum Cidofovir (dose of 5 mg/1 ml). Within the period from October 2001 to August 2004, ten patients aged between 5- and 70 years were treated with intralesional injections of Cidofovir. Papillomatosis was confirmed histologically in all cases, and the virus types were defined in part. Each of the patients underwent clinical-phoniatric examinations and was photographed for documentation. After 2-7 treatments with surgical laser papilloma ablation and intralesional Cidofovir injections, all patients showed a definite papilloma reduction, while in six cases complete remission was achieved. During the follow-up period of 8-30 months, not a single recurrence of the laryngeal papillomatosis occurred. In the majority of patients, a clear improvement in the voice was achieved. There were no local or systemic side effects caused by the virustaticum. Intralesional injection of Cidofovir is an adjuvant, but not a curative therapeutic option in recurrent laryngeal papillomatosis. Remission of previously frequently recurrent laryngeal papillomas can be achieved, but recurrence after longer treatment-free intervals is also possible.

    Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Publishing Authors By Initials

    a pudszuhnA Pudszuhn,c welzelC Welzel,m blochingM Bloching,k neumannK Neumann,a pudszuhnA Pudszuhn,c welzelC Welzel,m blochingM Bloching,k neumannK Neumann,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: European archives of oto-rhino-laryngology : offic

    VOLUME: 264

    Page Numbers: 63-70

    Journal Abbreviation:

    ISSN: 0937-4477

    DAY: 13

    MONTH: 10

    YEAR: 2006

    Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9002937

    Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Intralesional Cidofovir application in recurrent laryngeal papillomatosis.

    AFFILIATION: ENT Department, Head and Neck Surgery, Martin Luther University Halle-Wittenberg, Magdeburger Str. 12, 06097, Halle/Saale, Germany. kerstin.neumann@medizin.uni-halle.de

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur Arch Otorhinolaryngol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Intralesional Cidofovir application in recurrent laryngeal papillomatosis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News